Restless Leg Syndrome. Restless legs syndrome
Conditions
Interventions
Intervention 1: Intervention group: The hemodialysis fluid temperature (dialysate) will be adjusted to 35.5 ° C, while the filter type, the ratio of ultrafiltration of the filter, and the speed of the
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Informed consent to participate in the study Full consciousness and acceptable verbal and auditory ability to answer the questions The patient should not suffer from obvious mental disorder and severe mood - emotional disturbance that prevents effective communication The patient should be in normal neurological and vascular status. Lack of muscular and skeletal disorders debilitating physical activity Lack of ulcer and redness in limbs Patients with chronic renal failure (Patients who have been undergoing hemodialysis for 3 months). Patients who have an arteriovenous fistula, permanent catheter and arterial-venous graft can access their vessels. Patients undergoing hemodialysis three times a week and 4 hours each session. Patients who have had a history of restless leg syndrome during the past 2 months of hemodialysis. Lack of endocrine disorders (such as hypothyroidism and hyperparathyroidism). No history of itchy skin diseases Do not use medicines or foods that they exacerbate the leg syndrome during dialysis, such as: neuroleptics, triangular antidepressants, diphenhydramine, caffeine, alcohol, lithium, beta-blockers, selective serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors. Lack of liver problems No medication or treatments that affect on restless leg syndrome during dialysis(oral medicines, complementary medicine, acupuncture and topical softeners). Patients with KT / V =1 Patients with hemoglobin 10-11 mg / dL. Lack of febrile illness and chronic infections (pneumonia, cold during hemodialysis). Use of bicarbonate dialysis solution
Exclusion criteria
Exclusion criteria: Patients with catabolic processes such as: malignancies Diabetic neuropathy Cases of chronic infections, heart failure, chronic pulmonary disease, severe anemia, coronary artery disease and drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restless leg syndrome. Timepoint: Before and during and after the intervention. Method of measurement: International Restless Legs Syndrome Study Group Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring C-Reactive Protein (CRP). Timepoint: Before the intervention and after the intervention. Method of measurement: Use of CRP kits made by Company QCA Spain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Kashani
Sabzevar University of Medical Sciences
Outcome results
None listed